Prescribing guidance

These guidelines aim to provide a simple effective, economical and empirical approach to the treatment of common infections; to minimise the emergence of bacterial resistance in the community.

This guideline aims to reduce variation in inhaler prescribing in the management of adult asthma and encourage consideration of the decarbonisation agenda of NHS Wales.

The aim of the Care Home Medicines Optimisation Toolkit is to bring together a suite of guidance documents, tools and useful resources for care home staff and pharmacy teams who provide advice and support to care homes.

This document aims to guide best practice in the initiation; monitoring; review; tapering and stopping of antipsychotics for people living with dementia within NHS Wales

This guideline aims to reduce variation in inhaler prescribing in the management of chronic obstructive pulmonary disease (COPD) and encourage consideration of the decarbonisation agenda of NHS Wales.

This prescribing guidance document is intended for non-specialist practitioners engaged in supporting the prescribing and monitoring of medical therapies used in the management of gender incongruence in adults (over 18 years old). 

The Common Ailments Service aims to improve patient access to consistent, evidence-based advice for the management of common ailments. This document includes monographs for each of the ailments covered by the service.

These educational resources aim to support the prescribing of tramadol in NHS Wales within the complex context of pain management.

This document sets out the patient pathway for Wales, explicit in management options for each healthcare setting, referral thresholds, and national medication choices. It is a document for a national, standardised, safer and sustainable approach to asthma care in children.

The purpose of this document is to provide guidance for improving the management of unlicensed ‘specials’ and off-label medicines in all sectors of healthcare in NHS Wales. This guidance encompasses primary care (general practice and community pharmacy), secondary care, and patients and carers.

These resources aim to support the prescribing of medicines used in NHS Wales for the management of pain. The resources include an analgesic stewardship guidance document, and documents advising on the pharmacological management of pain. These resources update and replace the items previously listed on our website as ‘Persistent Pain Resources’.

This resource has been created to help support medicines optimisation in older patients who may be subject to inappropriate polypharmacy

This document presents an overview of the current situation regarding prescribing intervals, and sets out a series of recommendations on increasing prescribing intervals where appropriate.

The aim of these documents is to minimise the prescribing of medicines that offer a limited clinical benefit to patients and where more cost effective treatments may be available.

This guideline is aimed at all community and non-specialist medical, nursing and pharmacy staff involved in the prescribing and management of recurrent urinary tract infections (UTIs). This guideline is intended for non-pregnant, non-catheterised women aged 16 years and over.

This guidance provides an evidence-based, accessible, antimicrobial prescribing strategy for managing Clostridioides difficile infection (CDI) in adults.

This guidance focuses on treatment of patients with non-valvular atrial fibrillation (NVAF) and incorporates a risk/benefit assessment tool, and a one-page summary for Welsh healthcare practitioners choosing a direct oral anticoagulant in this patient population.

This document provides guidance for healthcare professionals regarding prescribing duration, foodstuffs, complementary medicines and alternative therapies, common ailments, fertility treatment, erectile dysfunction, prescribing for self and family, visitors from overseas, travel and occupational health vaccines, prescribing situations not covered by the NHS including private care and private prescriptions, unlicensed medicines and prescribing outside national guidance.